(2024)
Mod5 mediates a molecular trade-off between optimal gene expression and antifungal resistance.
bioRxiv
[Preprint]
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Medical & Environmental Metagenomics: human, mice, marine, plants;
- Systems Biology: -omics integration, chemical-protein & protein-protein interaction networks;
- Synthetic Biology: genome-scale metabolic modelling, design of probiotics, discovery of postbiotics
Publications
(2024)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese.
Comput Struct Biotechnol J 23(2024),
791-800.
(2024)
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver disease.
Probiotics Antimicrob Proteins
[Epub ahead of print]
(2024)
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.
Nat Metab ,
s42255-024-00988-y.
(2024)
Controlling substrate- and stereospecificity of condensation domains in nonribosomal peptide synthetases.
ACS Chem Bio 19(3),
599-606.
(2024)
Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκBmediated barrier protection.
Plos Pathogens 20(3),
e1012031.
(2023)
High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences.
Microbiol Spectr 11(3),
e0049823.
(2023)
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Nat Immunol 24(2),
295-308.
(2023)
Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions.
Microbiome 11(1),
178.
(2023)
Gut ecological networks reveal associations between bacteria, exercise and clinical profile in non-alcoholic fatty liver disease patients.
mSystems 8(5),
e0022423.